Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06979726
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06979726
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06979726. Allocation not applicable; no masking; primary purpose treatment. Start 2025-11-20 (actual); primary completion 2026-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
- Acronym
- GatorScalesWHF
- Condition
- Heart Failure
- Condition
- Volume Overload
- Intervention (Drug)
- Lasix ONYU
- Lead sponsor
- University of Florida
- Collaborator
- SQ Innovation, Inc.
Record details
- Record id
cardio:ct-nct06979726- Content hash
46237fc8078a090871d63793ec90c515664d541b46c1ba89b4e42db466c8dd6d